Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 200

1.

The role of B cells and autoantibodies in neuropsychiatric lupus.

Wen J, Stock AD, Chalmers SA, Putterman C.

Autoimmun Rev. 2016 Jul 5. pii: S1568-9972(16)30144-6. doi: 10.1016/j.autrev.2016.07.009. [Epub ahead of print] Review.

PMID:
27389531
2.

Fn14 deficiency protects lupus-prone mice from histological lupus erythematosus-like skin inflammation induced by ultraviolet light.

Doerner J, Chalmers SA, Friedman A, Putterman C.

Exp Dermatol. 2016 Jun 15. doi: 10.1111/exd.13108. [Epub ahead of print]

PMID:
27305603
3.

Therapeutic Blockade of Immune Complex-Mediated Glomerulonephritis by Highly Selective Inhibition of Bruton's Tyrosine Kinase.

Chalmers SA, Doerner J, Bosanac T, Khalil S, Smith D, Harcken C, Dimock J, Der E, Herlitz L, Webb D, Seccareccia E, Feng D, Fine JS, Ramanujam M, Klein E, Putterman C.

Sci Rep. 2016 May 19;6:26164. doi: 10.1038/srep26164.

4.

Urinary high-mobility group box-1 associates specifically with lupus nephritis class V.

Jog NR, Blanco I, Lee I, Putterman C, Caricchio R.

Lupus. 2016 Apr 12. pii: 0961203316644331. [Epub ahead of print]

PMID:
27075010
5.

B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.

Wen J, Doerner J, Chalmers S, Stock A, Wang H, Gullinello M, Shlomchik MJ, Putterman C.

J Neuroinflammation. 2016 Apr 7;13(1):73. doi: 10.1186/s12974-016-0537-3.

6.

Insulin-Like Growth Factor Binding Protein-4 as a Marker of Chronic Lupus Nephritis.

Wu T, Xie C, Han J, Ye Y, Singh S, Zhou J, Li Y, Ding H, Li QZ, Zhou X, Putterman C, Saxena R, Mohan C.

PLoS One. 2016 Mar 28;11(3):e0151491. doi: 10.1371/journal.pone.0151491. eCollection 2016.

7.

Intracerebroventricular administration of TNF-like weak inducer of apoptosis induces depression-like behavior and cognitive dysfunction in non-autoimmune mice.

Wen J, Chen CH, Stock A, Doerner J, Gulinello M, Putterman C.

Brain Behav Immun. 2016 May;54:27-37. doi: 10.1016/j.bbi.2015.12.017. Epub 2015 Dec 23.

PMID:
26721417
8.

Association between antiphospholipid antibodies and all-cause mortality among end-stage renal disease patients with and without SLE: a retrospective cohort study.

Broder A, Mowrey WB, Kim M, Murakhovskaya I, Billett H, Neugarten J, Costenbader KH, Putterman C.

Rheumatology (Oxford). 2016 May;55(5):817-25. doi: 10.1093/rheumatology/kev423. Epub 2015 Dec 24.

9.

SLE-key(®) rule-out serologic test for excluding the diagnosis of systemic lupus erythematosus: Developing the ImmunArray iCHIP(®).

Putterman C, Wu A, Reiner-Benaim A, Batty DS Jr, Sanz I, Oates J, Jakobi K, Petri M, Safer P, Gerwien R, Sorek R, Blumenstein Y, Cohen IR.

J Immunol Methods. 2016 Feb;429:1-6. doi: 10.1016/j.jim.2015.12.003. Epub 2015 Dec 8.

PMID:
26678162
10.

What Is a Rheumatologist and How Do We Make One?

Brown CR Jr, Criscione-Schreiber L, O'Rourke KS, Fuchs HA, Putterman C, Tan IJ, Valeriano-Marcet J, Hsieh E, Zirkle S, Bolster MB.

Arthritis Care Res (Hoboken). 2016 Aug;68(8):1166-72. doi: 10.1002/acr.22817.

11.

Anti-DNA antibody mediated catalysis is isotype dependent.

Xia Y, Eryilmaz E, Zhang Q, Cowburn D, Putterman C.

Mol Immunol. 2016 Jan;69:33-43. doi: 10.1016/j.molimm.2015.11.001. Epub 2015 Dec 1.

PMID:
26655427
12.

The Role of Anti-DNA Antibodies in the Development of Lupus Nephritis: A Complementary, or Alternative, Viewpoint?

Goilav B, Putterman C.

Semin Nephrol. 2015 Sep;35(5):439-43. doi: 10.1016/j.semnephrol.2015.08.005. Review.

PMID:
26573546
13.

Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.

Stock AD, Wen J, Doerner J, Herlitz LC, Gulinello M, Putterman C.

J Neuroinflammation. 2015 Nov 6;12:205. doi: 10.1186/s12974-015-0423-4.

14.

A peptide mimic blocks the cross-reaction of anti-DNA antibodies with glomerular antigens.

Xia Y, Eryilmaz E, Der E, Pawar RD, Guo X, Cowburn D, Putterman C.

Clin Exp Immunol. 2016 Mar;183(3):369-79. doi: 10.1111/cei.12734. Epub 2015 Dec 8.

PMID:
26482679
15.

Therapeutic targeting of macrophages in lupus nephritis.

Chalmers SA, Chitu V, Ramanujam M, Putterman C.

Discov Med. 2015 Jul-Aug;20(108):43-9. Review.

16.

Extracellular RNAs: development as biomarkers of human disease.

Quinn JF, Patel T, Wong D, Das S, Freedman JE, Laurent LC, Carter BS, Hochberg F, Van Keuren-Jensen K, Huentelman M, Spetzler R, Kalani MY, Arango J, Adelson PD, Weiner HL, Gandhi R, Goilav B, Putterman C, Saugstad JA.

J Extracell Vesicles. 2015 Aug 28;4:27495. doi: 10.3402/jev.v4.27495. eCollection 2015.

17.

Biomarkers for CNS involvement in pediatric lupus.

Rubinstein TB, Putterman C, Goilav B.

Biomark Med. 2015;9(6):545-58. doi: 10.2217/bmm.15.26. Review.

18.

Biomarkers for kidney involvement in pediatric lupus.

Goilav B, Putterman C, Rubinstein TB.

Biomark Med. 2015;9(6):529-43. doi: 10.2217/bmm.15.25. Review.

19.

Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritis.

Seret G, Cañas F, Pougnet-Di Costanzo L, Hanrotel-Saliou C, Jousse-Joulin S, Le Meur Y, Saraux A, Valeri A, Putterman C, Youinou P, Rojas-Villarraga A, Anaya JM, Renaudineau Y.

J Autoimmun. 2015 Jul;61:54-61. doi: 10.1016/j.jaut.2015.05.009. Epub 2015 Jun 10.

PMID:
26071203
20.

Differential Development of Systemic Lupus Erythematosus in NZM 2328 Mice Deficient in Discrete Pairs of BAFF Receptors.

Jacob CO, Yu N, Sindhava V, Cancro MP, Pawar RD, Putterman C, Stohl W.

Arthritis Rheumatol. 2015 Sep;67(9):2523-35. doi: 10.1002/art.39210.

PMID:
25989238
Items per page

Supplemental Content

Loading ...
Write to the Help Desk